SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-19-000189
Filing Date
2019-02-12
Accepted
2019-02-12 16:15:21
Documents
1
Group Members
DEERFIELD INTERNATIONAL MASTER FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e618186_sc13ga-recro.htm SC 13G/A 125027
  Complete submission text file 0001193805-19-000189.txt   126472
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Subject) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88042 | Film No.: 19590951
SIC: 2834 Pharmaceutical Preparations